| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/25/2001 | US20010034018 Contacting a sample with an antibody which binds to SVI (Sentinel virus 1) or a protein and the antibody does not bind TTV strains SANBAN and TUS01 or protiens and detecting the complexes of antibody and SVI virus or protein |
| 10/25/2001 | US20010033863 Using robots |
| 10/25/2001 | US20010033841 Atherosclerosis therapy |
| 10/25/2001 | US20010033808 Method and assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample |
| 10/25/2001 | US20010033414 Apparatus and method for observing biochemical substance |
| 10/25/2001 | US20010033371 Quantum dots, semiconductor nanocrystals and semiconductor particles used as fluorescent coding elements |
| 10/25/2001 | US20010033364 Spectral bio-imaging of the eye |
| 10/25/2001 | US20010032582 Filling an oil in crystallization wells, providing a cocktail and protein solutions that co-dilute, incubating, inspecting, scoring the results |
| 10/25/2001 | EP1145008A3 Method and device for diagnosing allergy symptoms |
| 10/25/2001 | DE10019853A1 Gassensoranordnung Gas sensor array |
| 10/25/2001 | DE10018963A1 Determination of iodinated thyroglobulin, useful for detecting residual thyroid cancer or metastases after surgery, comprises immunoassay after administration of 131-iodine |
| 10/25/2001 | DE10018508A1 Method of sensing and calculating or simulating the propagation of smells or odors |
| 10/25/2001 | DE10018506A1 Apparatus for sensing and calculating or simulating the propagation of smells or odors |
| 10/25/2001 | DE10018433A1 Sensor system used for determining the quality of tap water, comprises a chamber having an inlet and an outlet, a substrate on which algae is grown, oxygen sensors, pH sensors, and optionally temperature sensors |
| 10/25/2001 | DE10013993A1 Article with activated surface for binding macromolecules, useful for making e.g. sensors or arrays, comprises dendrimer framework, containing reactive groups, on a substrate |
| 10/25/2001 | DE10007792A1 Differential diagnosis of autoantibodies against thyroid stimulating hormone receptor in patients sample, useful to detect different thyroid autoimmune diseases including Grave's disease |
| 10/25/2001 | CA2798625A1 Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins |
| 10/25/2001 | CA2407064A1 Screening assay methods and systems using target pooling |
| 10/25/2001 | CA2406955A1 Sheep lice, bovicola ovis, allergen treatment |
| 10/25/2001 | CA2406635A1 A method of fabricating coded particles |
| 10/25/2001 | CA2406481A1 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 10/25/2001 | CA2406383A1 A.beta.42 lowering agents |
| 10/25/2001 | CA2406346A1 Genetic testing for determining the risk of pouchitis development |
| 10/25/2001 | CA2406309A1 Method and apparatus for selective biological material detection |
| 10/25/2001 | CA2406308A1 Method and apparatus for selective biological material detection |
| 10/25/2001 | CA2406288A1 Diagnostic assay for endometriosis |
| 10/25/2001 | CA2406195A1 Lipid binding protein 4 |
| 10/25/2001 | CA2406190A1 Screening method for compounds |
| 10/25/2001 | CA2406133A1 Biosensor and related method |
| 10/25/2001 | CA2406087A1 New lipid binding protein 2 |
| 10/25/2001 | CA2406066A1 Lipid binding protein 3 |
| 10/25/2001 | CA2405781A1 Secreted proteins |
| 10/25/2001 | CA2405711A1 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| 10/25/2001 | CA2405548A1 Steatosis-modulating factors and uses thereof |
| 10/25/2001 | CA2405456A1 Detection and amplification of rna using target-mediated ligation of dna by rna ligase |
| 10/25/2001 | CA2405451A1 Molecules associated with human reproduction |
| 10/25/2001 | CA2405440A1 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 10/25/2001 | CA2405412A1 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction |
| 10/25/2001 | CA2404929A1 Prediction of molecular polar surface area and bioabsorption |
| 10/25/2001 | CA2404240A1 Device for detecting analytes related to sample ph |
| 10/25/2001 | CA2404127A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 10/25/2001 | CA2403644A1 Drug metabolizing enzymes |
| 10/25/2001 | CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 10/25/2001 | CA2403508A1 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 10/25/2001 | CA2376655A1 Modulating cell survival by modulating huntingtin function |
| 10/24/2001 | EP1148339A2 Immunoassay for LSD and 2-Oxo-3-Hydroxy-LSD |
| 10/24/2001 | EP1148338A2 Method for determining eta phase copper |
| 10/24/2001 | EP1148337A2 Method for analyzing impurities in a gas stream |
| 10/24/2001 | EP1148329A1 Device for determining the water content of fresh concrete |
| 10/24/2001 | EP1148119A1 Hybridization device, case, support, and label agent |
| 10/24/2001 | EP1147741A1 Medical measuring device |
| 10/24/2001 | EP1147739A2 Subscription based biosensor monitoring system and method |
| 10/24/2001 | EP1147423A1 A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample |
| 10/24/2001 | EP1147422A1 Assays for modulators of "elongation factor p" activity |
| 10/24/2001 | EP1147421A1 Method and diagnostic kit for diagnosis of endometriosis |
| 10/24/2001 | EP1147420A1 Urinary trypsin inhibitor to diagnose aids |
| 10/24/2001 | EP1147419A2 Labeling, immobilisation, enrichment, purification and detection of cells using specific domains that bind to the cell walls (cbd) of proteins binding to the drawn cell walls of viruses, bacteria or eukaryotic cells |
| 10/24/2001 | EP1147418A1 Methods for detecting an analyte of interest using tyramide coating technology |
| 10/24/2001 | EP1147416A2 Assays involving colloids and non-colloidal structures |
| 10/24/2001 | EP1147415A1 Method and kit for extracting prion protein |
| 10/24/2001 | EP1147414A1 Method and kit for identifying or characterising polypeptides |
| 10/24/2001 | EP1147413A2 Growth differentiation factor inhibitors and uses therefor |
| 10/24/2001 | EP1147412A1 Method for determining platelet inhibitor response |
| 10/24/2001 | EP1147411A1 Contaminant detection |
| 10/24/2001 | EP1147410A1 Method for non-destructive assessment and selection of products according to their quality and implementing device |
| 10/24/2001 | EP1147409A1 Separation of charged particles by a spatially and temporally varying electric field |
| 10/24/2001 | EP1147400A1 Method and apparatus for performing cell analysis based on simultaneous multiple marker emissions from neoplasia (casmmen) |
| 10/24/2001 | EP1147399A1 Method and device for measuring blood parameters |
| 10/24/2001 | EP1147395A1 Optical analysis of grain stream |
| 10/24/2001 | EP1147225A1 Multiplex real-time pcr |
| 10/24/2001 | EP1147224A1 Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes |
| 10/24/2001 | EP1147223A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 10/24/2001 | EP1147222A1 Replicable probe array |
| 10/24/2001 | EP1147219A1 Analysis method |
| 10/24/2001 | EP1147217A1 A method of dna sequencing |
| 10/24/2001 | EP1147215A1 Diagnostic test for the measurement of analyte in a biological fluid |
| 10/24/2001 | EP1147214A1 A novel method for designing protein kinase inhibitors |
| 10/24/2001 | EP1147213A2 Novel rgs-containing molecules and uses thereof |
| 10/24/2001 | EP1147203A1 Mammalian serine racemase |
| 10/24/2001 | EP1147196A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains |
| 10/24/2001 | EP1147195A1 Candida albicans srb-7 |
| 10/24/2001 | EP1147194A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 10/24/2001 | EP1147193A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof |
| 10/24/2001 | EP1147187A2 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
| 10/24/2001 | EP1147183A1 Nucleic acid and amino acid sequences |
| 10/24/2001 | EP1147179A2 Human liver progenitors |
| 10/24/2001 | EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 10/24/2001 | EP1147133A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 10/24/2001 | EP1147128A1 Binding molecules for human factor viii and factor viii-like proteins |
| 10/24/2001 | EP1147123A2 Novel odorant receptors in drosophila |
| 10/24/2001 | EP1146968A1 Process for attaching organic molecules to silicon |
| 10/24/2001 | EP1146963A1 Nucleic acid amplification reaction station for disposable test devices |
| 10/24/2001 | EP1146909A1 Method of treating cancer by restoration of pp32 function |
| 10/24/2001 | EP1146903A1 Glypicans for the detection and treatment of human carcinoma |
| 10/24/2001 | EP1146902A1 Treatment of autommune diseases by an agonistic cd40-binding protein |
| 10/24/2001 | EP1146889A2 Identification of specific differentially expressed mycobacterial antigens |
| 10/24/2001 | EP1146888A2 Specific therapeutic interventions obtained by interference with redistribution and/or targetting |
| 10/24/2001 | EP1146881A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 10/24/2001 | EP1146869A2 Inhibition of stat3 signal transduction for human cancer therapy |
| 10/24/2001 | EP1146787A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |